Literature DB >> 12433710

Low-penetrance genes and their involvement in colorectal cancer susceptibility.

Mirjam M de Jong1, Ilja M Nolte, Gerard J te Meerman, Winette T A van der Graaf, Elisabeth G E de Vries, Rolf H Sijmons, Robert M W Hofstra, Jan H Kleibeuker.   

Abstract

This report focuses on low-penetrance genes that are associated with colorectal adenoma and/or cancer or that are in strong linkage disequilibrium with colorectal adenoma and/or cancer causing variants. A pooled analysis was performed for 30 polymorphisms in 20 different genes that have been reported in more than one colorectal adenoma or cancer study. An association with colorectal cancer was found for seven polymorphisms in seven genes reported in more than one study; no associations were found with colorectal adenoma. Four of the polymorphisms exhibited an increased colorectal cancer risk [GSTT1, NAT2 (phenotype), HRAS1, and ALDH2]. Two others [MTHFR, Tp53 (intron 3)] exhibited a decreased risk. For the tumor necrosis factor (TNF)a polymorphism of the TNF-alpha gene, one allele was associated with an increased risk (a2 allele) and two other TNFa alleles with decreased risks (a5 and a13 allele). No association with colorectal adenoma and/or cancer was detected for 23 other polymorphisms in 15 genes. However, of all 30 polymorphisms, only three pooled analyses had sufficiently large samples to confirm (MTHFR) or to exclude (GSTM1 and NAT2 genotype) the association with a P < 0.0026 and a power of 90%. Eighteen polymorphisms in 15 genes were each described in only one study, all with very small sample sizes. For 11 polymorphisms in 10 of these genes, an association with colorectal adenoma and/or cancer was found. Only simultaneous genotyping and combined analysis of different polymorphisms in large numbers of patients and controls, stratified by ethnicity, gender, and tumor localization and taking relevant dietary and lifestyle habits into account, will make it possible to describe the exact relations between polymorphisms and colorectal cancer susceptibility with an adequate power.

Entities:  

Mesh:

Year:  2002        PMID: 12433710

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  46 in total

1.  Colorectal adenomas and cancer link to chromosome 13q22.1-13q31.3 in a large family with excess colorectal cancer.

Authors:  Deborah W Neklason; Thérèse M Tuohy; Jeffery Stevens; Brith Otterud; Lisa Baird; Richard A Kerber; Wade S Samowitz; Scott K Kuwada; Mark F Leppert; Randall W Burt
Journal:  J Med Genet       Date:  2010-06-03       Impact factor: 6.318

2.  No association between XRCC3 Thr241Met and XPD Lys751Gln polymorphisms and the risk of colorectal cancer in West Algerian population: a case-control study.

Authors:  Fatima Zohra Moghtit; Meriem Samia Aberkane; Valérie Le Morvan; Lotfi Louhibi; Ricardo Bellot; Abdelkader Bousahba; Ahlem Megaiz; Mostefa Fodil; Sounnia Mediene-Benchekor; Faouzia Zemani-Fodil; Abdallah Boudjema; Jacques Robert; Nadhira Saidi-Mehtar
Journal:  Med Oncol       Date:  2014-04-01       Impact factor: 3.064

3.  Reprimo 824 G>C and p53R2 4696 C>G single nucleotide polymorphisms and colorectal cancer: a case-control disease association study.

Authors:  William D Beasley; John Beynon; Gareth J S Jenkins; Jim M Parry
Journal:  Int J Colorectal Dis       Date:  2008-04       Impact factor: 2.571

4.  Gut health, genetics and personalised nutrition.

Authors:  Ian T Johnson
Journal:  Genes Nutr       Date:  2007-10       Impact factor: 5.523

Review 5.  Genetic susceptibility to cancer: the role of polymorphisms in candidate genes.

Authors:  Linda M Dong; John D Potter; Emily White; Cornelia M Ulrich; Lon R Cardon; Ulrike Peters
Journal:  JAMA       Date:  2008-05-28       Impact factor: 56.272

6.  Associations analysis of GSTM1, T1 and P1 Ile105Val polymorphisms with carpal tunnel syndrome.

Authors:  Pınar Eroğlu; Esra Erkol İnal; Şebnem Özemri Sağ; Özlem Görükmez; Ali Topak; Tahsin Yakut
Journal:  Clin Rheumatol       Date:  2015-01-09       Impact factor: 2.980

7.  The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer.

Authors:  Steven J Hawken; Celia M T Greenwood; Thomas J Hudson; Rafal Kustra; John McLaughlin; Quanhe Yang; Brent W Zanke; Julian Little
Journal:  Hum Genet       Date:  2010-05-01       Impact factor: 4.132

8.  The Swedish family-cancer database: update, application to colorectal cancer and clinical relevance.

Authors:  Kari Hemminki; Charlotta Granström; Bowang Chen
Journal:  Hered Cancer Clin Pract       Date:  2005-01-15       Impact factor: 2.857

9.  Microsomal glutathione S-transferase gene polymorphisms and colorectal cancer risk in a Han Chinese population.

Authors:  Hao Zhang; Ling-Hong Liao; Shuk-Ming Liu; Kwok-Wai Lau; Albert Kai-Cheong Lai; Jin-Hui Zhang; Qi Wang; Xiao-Qian Chen; Wei Wei; Hua Liu; Jian-Hua Cai; Maria Li Lung; Susan S W Tai; Madeline Wu
Journal:  Int J Colorectal Dis       Date:  2007-05-05       Impact factor: 2.571

10.  COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer.

Authors:  I P M Tomlinson; M Dunlop; H Campbell; B Zanke; S Gallinger; T Hudson; T Koessler; P D Pharoah; I Niittymäki; I Niittymäkix; S Tuupanen; S Tuupanenx; L A Aaltonen; K Hemminki; A Lindblom; A Försti; O Sieber; L Lipton; T van Wezel; H Morreau; J T Wijnen; P Devilee; K Matsuda; Y Nakamura; S Castellví-Bel; C Ruiz-Ponte; A Castells; A Carracedo; J W C Ho; P Sham; R M W Hofstra; P Vodicka; H Brenner; J Hampe; C Schafmayer; J Tepel; S Schreiber; H Völzke; M M Lerch; C A Schmidt; S Buch; V Moreno; C M Villanueva; P Peterlongo; P Radice; M M Echeverry; A Velez; L Carvajal-Carmona; R Scott; S Penegar; P Broderick; A Tenesa; R S Houlston
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.